IDR 3580.0
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -183.3 Billion IDR | -18.84% |
2022 | -154.24 Billion IDR | 12.39% |
2021 | -176.06 Billion IDR | -56.21% |
2020 | -112.7 Billion IDR | 29.66% |
2019 | -160.22 Billion IDR | 59.98% |
2018 | -400.32 Billion IDR | -612.52% |
2017 | -56.18 Billion IDR | 50.9% |
2016 | -114.43 Billion IDR | 18.74% |
2015 | -140.83 Billion IDR | 45.29% |
2014 | -257.41 Billion IDR | -39.73% |
2013 | -184.22 Billion IDR | -28.33% |
2012 | -143.55 Billion IDR | 43.42% |
2011 | -253.73 Billion IDR | -135.16% |
2010 | -107.89 Billion IDR | -36.0% |
2009 | -79.33 Billion IDR | 40.86% |
2008 | -134.14 Billion IDR | -40.82% |
2007 | -95.25 Billion IDR | -20.29% |
2006 | -79.18 Billion IDR | -228.06% |
2005 | -24.13 Billion IDR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -71.49 Billion IDR | 0.42% |
2024 Q1 | -180.08 Billion IDR | 1.75% |
2024 Q2 | -58.47 Billion IDR | 67.53% |
2023 Q3 | -153.77 Billion IDR | -50.81% |
2023 Q1 | -211.88 Billion IDR | -37.37% |
2023 FY | -183.3 Billion IDR | -18.84% |
2023 Q4 | -183.3 Billion IDR | -19.2% |
2023 Q2 | -101.96 Billion IDR | 51.88% |
2022 FY | -154.24 Billion IDR | 12.39% |
2022 Q1 | -218.62 Billion IDR | -24.18% |
2022 Q4 | -154.24 Billion IDR | -67.07% |
2022 Q2 | -112.78 Billion IDR | 48.41% |
2022 Q3 | -92.32 Billion IDR | 18.14% |
2021 Q2 | -197.06 Billion IDR | -40.15% |
2021 FY | -176.06 Billion IDR | -56.21% |
2021 Q4 | -176.06 Billion IDR | 8.72% |
2021 Q1 | -140.6 Billion IDR | -24.76% |
2021 Q3 | -192.87 Billion IDR | 2.12% |
2020 Q3 | -43.24 Billion IDR | 47.6% |
2020 Q1 | -107.7 Billion IDR | 32.78% |
2020 Q2 | -82.52 Billion IDR | 23.38% |
2020 FY | -112.7 Billion IDR | 29.66% |
2020 Q4 | -112.7 Billion IDR | -160.63% |
2019 Q2 | -59.55 Billion IDR | 82.72% |
2019 Q3 | -83.27 Billion IDR | -39.83% |
2019 Q4 | -160.22 Billion IDR | -92.41% |
2019 Q1 | -344.6 Billion IDR | 13.92% |
2019 FY | -160.22 Billion IDR | 59.98% |
2018 Q2 | -136.75 Billion IDR | -122.29% |
2018 FY | -400.32 Billion IDR | -612.52% |
2018 Q4 | -400.32 Billion IDR | -567.47% |
2018 Q3 | -59.97 Billion IDR | 56.14% |
2018 Q1 | -61.52 Billion IDR | -9.5% |
2017 Q2 | 4.72 Billion IDR | 109.75% |
2017 Q1 | -48.47 Billion IDR | 57.64% |
2017 FY | -56.18 Billion IDR | 50.9% |
2017 Q4 | -56.18 Billion IDR | -1520.23% |
2017 Q3 | -3.46 Billion IDR | -173.35% |
2016 Q3 | -74.26 Billion IDR | -498.86% |
2016 FY | -114.43 Billion IDR | 18.74% |
2016 Q4 | -114.43 Billion IDR | -54.08% |
2016 Q2 | -12.4 Billion IDR | 86.41% |
2016 Q1 | -91.28 Billion IDR | 35.18% |
2015 FY | -140.83 Billion IDR | 45.29% |
2015 Q1 | -211.19 Billion IDR | 17.96% |
2015 Q2 | -135.07 Billion IDR | 36.04% |
2015 Q3 | -173.57 Billion IDR | -28.51% |
2015 Q4 | -140.83 Billion IDR | 18.87% |
2014 Q3 | -203.56 Billion IDR | -292.89% |
2014 FY | -257.41 Billion IDR | -39.73% |
2014 Q2 | -51.81 Billion IDR | 73.07% |
2014 Q4 | -257.41 Billion IDR | -26.45% |
2014 Q1 | -192.43 Billion IDR | -4.45% |
2013 FY | -184.22 Billion IDR | -28.33% |
2013 Q2 | -133.59 Billion IDR | 17.47% |
2013 Q1 | -161.87 Billion IDR | -12.77% |
2013 Q4 | -184.22 Billion IDR | -6.14% |
2013 Q3 | -173.56 Billion IDR | -29.92% |
2012 Q1 | -254.64 Billion IDR | -0.36% |
2012 FY | -143.55 Billion IDR | 43.42% |
2012 Q4 | -143.55 Billion IDR | 22.57% |
2012 Q3 | -185.38 Billion IDR | -54.18% |
2012 Q2 | -120.23 Billion IDR | 52.78% |
2011 Q4 | -253.73 Billion IDR | 0.0% |
2011 Q1 | -142.81 Billion IDR | -32.36% |
2011 FY | -253.73 Billion IDR | -135.16% |
2010 Q4 | -107.89 Billion IDR | 18.99% |
2010 FY | -107.89 Billion IDR | -36.0% |
2010 Q1 | -63.72 Billion IDR | 19.68% |
2010 Q3 | -133.18 Billion IDR | 0.0% |
2009 Q4 | -79.33 Billion IDR | 0.0% |
2009 FY | -79.33 Billion IDR | 40.86% |
2008 FY | -134.14 Billion IDR | -40.82% |
2007 FY | -95.25 Billion IDR | -20.29% |
2006 FY | -79.18 Billion IDR | -228.06% |
2005 FY | -24.13 Billion IDR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | -238.56 Billion IDR | 23.165% |
PT Phapros, Tbk | 736.73 Billion IDR | 124.88% |
PT Pyridam Farma Tbk | 897.02 Billion IDR | 120.435% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | -820.73 Billion IDR | 77.666% |
PT Tempo Scan Pacific Tbk | -2577.85 Billion IDR | 92.889% |